telehealth weight loss services glp-1 medications coaching Fridays | Impact of Digital Engagement on

The FDA has not approved semaglutide (Wegovy) for weight loss in patients under 18

Review Article Abstract Introduction Retatrutide for Treatment of Obesity Retatrutide for Treatment of Type 2 Diabetes Effects of Retatrutide on Cardiovascular Risk Factors Safety of Retatrutide Effect of Retatrutide on Heart Rate Advantages of Retatrutide Limitations of Retatrutide Conclusions and Current Needs References Retatrutide for Treatment of Type 2 Diabetes In another phase 2 trial in the USA, retatrutide was evaluated for treatment of type 2 diabetes in comparison with subcutaneous dulaglutide (1.5mg/weekly) and placebo (Table 1) [4]

10.1152/ajpendo.00464.2009 98 PocaiA.CarringtonP

Thats the promise GLP-1 medications are making, and theyre turning heads across the health world